US.LH · Labcorp

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.0171168567021103,
        "turnoverUsdM": 235.49701198602997,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.LH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 324.0572,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4,
      "take_profit_price": 354.564,
      "target_multiplier": 1.9,
      "technical_strength": 1.85,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2393927459846728,
    "stopLossPercent": 4.0342337134042205,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 72.7,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 61.7,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 11
  },
  "market": {
    "ma20": 321.568,
    "ma50": 295.1718,
    "close": 337.68,
    "prevClose": 339.34,
    "avgVolume20": 665900,
    "volumeRatio": 1.05,
    "changePercent": -0.49
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 11,
    "details": {
      "ret_5d": 0.048109753805628985,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 11,
      "vcp_bonus": 0,
      "vol_ratio": 1.0138942195859502,
      "ret_points": 8,
      "vol_points": 2,
      "range_ratio": 0.7273711960093352,
      "volat_points": 0,
      "day_range_pct": 0.018449449729017256,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 72.7,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 66,
        "contribution": 3.3
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 22.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 74,
        "contribution": 22.2
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 61.7,
    "details": [
      "基本面分析總分: 3.3/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 22.2/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.3,
      "資金流": 12.4,
      "市場環境": 8.6,
      "情緒分析": 6,
      "技術信號": 22.2,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0.6,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 235.49701198602997,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 3.2,
          "mfiPoints": 0.8,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.LH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.85
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 712.1600008500002,
                "ma50": 713.0132008399997,
                "name": "QQQ",
                "close": 710.71997,
                "points": 0.4
              },
              "spy": {
                "ma20": 764.7984983,
                "ma50": 752.747003,
                "name": "SPY",
                "close": 765.90997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.0171168567021103,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 5,
              "sentimentScoreRaw": 1.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141195498,
                "url": "https://finnhub.io/api/news?id=52a9e9c710389d8e328c113ec8d19bb6fe8cdf20776be938d5fee35bc4b11809",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced melanoma and nationwide access to Roche's VENTANA PTEN RxDx Assay for prostate cancer. See our latest analysis for Labcorp Holdings. Labcorp Holdings has attracted more attention in recent months, with oncology diagnostics approvals and stronger earnings updates sitting alongside a 30 day share price return of 16.48% and a 1 year total...",
                "category": "company",
                "datetime": 1786554523,
                "headline": "Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?"
              },
              {
                "id": 141195499,
                "url": "https://finnhub.io/api/news?id=113fd9a31a9520a3488b53c1dc4d4d6b3879247f5450043b998c69734cadd53d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "In late July and early August 2026, Labcorp reported higher second-quarter and year-to-date earnings, raised its 2026 revenue growth guidance, completed a large share repurchase program, and expanded its precision oncology offering by making Roche's FDA-approved VENTANA PTEN (SP218) RxDx Assay available nationwide to help guide prostate cancer treatment decisions. Together with the recent FDA approval of its PGDx elio tissue complete CDx for advanced melanoma, these developments reinforce...",
                "category": "company",
                "datetime": 1786513280,
                "headline": "Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative?"
              },
              {
                "id": 141104982,
                "url": "https://finnhub.io/api/news?id=295204cd4af9efb6610e72a4dabb7c24f5d072f220625e367e538daf94479f5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Specialty testing and Central Labs fueled revenue growth and margin expansion.",
                "category": "company",
                "datetime": 1785802612,
                "headline": "Labcorp (LH) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141083725,
                "url": "https://finnhub.io/api/news?id=4d79c685225036b140b62d42ebb2df3bbf5c2d184593de5cc537c8916de1b921",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE:LH) has introduced the Marker by Labcorp Genetic Health Panel, a new consumer-focused genetic testing service. The product brings together genetic testing, counseling, and biomarker analysis in one offering for individuals looking to better understand their health risks. The launch uses Labcorp’s existing testing infrastructure alongside new AI-powered platforms to support more tailored insights for consumers. Investors watching Labcorp Holdings now have a fresh data...",
                "category": "company",
                "datetime": 1785539301,
                "headline": "Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing"
              },
              {
                "id": 141083726,
                "url": "https://finnhub.io/api/news?id=41496f8d4329a454733b8c76cbcd2d949f209ba3226e43423edd777467a44f22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.77 billion at the midpoint. Its non-GAAP profit of $4.99 per share was 4.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785538797,
                "headline": "LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase"
              },
              {
                "id": 141071710,
                "url": "https://finnhub.io/api/news?id=d549868b4a230c3a0c0c3c7ad7bf79f11d867424ed4dbfab41fcb66c19e2fde6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc (LH) reports a 6% revenue increase to $3.7 billion and raises full-year 2026 guidance, driven by double-digit growth in specialty testing and robust Biopharma segment performance.",
                "category": "company",
                "datetime": 1785445728,
                "headline": "Labcorp Holdings Inc (LH) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ..."
              },
              {
                "id": 141068617,
                "url": "https://finnhub.io/api/news?id=05552d6ffcc25a073722abed7f9de34a3d2ebb547fb64e72bc837087eb718b16",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp's Q2 earnings and revenues surpass estimates, margins expand, and its 2026 outlook is raised, but shares fall 6% in pre-market trading.",
                "category": "company",
                "datetime": 1785425340,
                "headline": "LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Rise"
              },
              {
                "id": 141069063,
                "url": "https://finnhub.io/api/news?id=143177d8f1fb7ff7ef9861ff610a92acb5586305f8dca5604f2f600c1f832396",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call July 30, 2026 9:00 AM EDTCompany ParticipantsDewey SteadmanAdam Schechter - President, CEO &...",
                "category": "company",
                "datetime": 1785422617,
                "headline": "Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript"
              }
            ],
            "raw_source": [
              {
                "id": 141313625,
                "url": "https://finnhub.io/api/news?id=bf0775da347333c805e2171fe144b86c4c7a909f48cddbae25b312b5df9f684d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys® pTau-217 test following clearance by the U.S. Food and Drug Administration (FDA). Developed by Roche Diagnostics, the blood test aids in identifying amyloid pathology associated with Alzheimer's disease in individuals 55 and older with signs, symptoms or complaints of cognitive decline. Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test",
                "category": "company",
                "datetime": 1787569320,
                "headline": "Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings"
              },
              {
                "id": 141311514,
                "url": "https://finnhub.io/api/news?id=ea8b7c842e72dc4a35a5969cc5038e4bcce5289bd7456967e5649d34ae7c971c",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settingsMeasures phosphorylated Tau 217 (pTau-217), an",
                "category": "company",
                "datetime": 1787555281,
                "headline": "Labcorp To Offer Elecsys pTau-217 Test Following Clearance By FDA"
              },
              {
                "id": 141275203,
                "url": "https://finnhub.io/api/news?id=089773ba910b7d77165aa048f75b768edf24f1414da740123cd9e15d62e665de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "The gap between its revenue multiple and its cash multiple is margin, and the company is spending it on purpose.",
                "category": "company",
                "datetime": 1787257290,
                "headline": "Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash"
              },
              {
                "id": 141266861,
                "url": "https://finnhub.io/api/news?id=9cedcdf4c43cd7438e7b70ae9a03e3c4bf570d0f0bd5b655596aaaef72271d12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.",
                "category": "company",
                "datetime": 1787243820,
                "headline": "IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve"
              },
              {
                "id": 141283687,
                "url": "https://finnhub.io/api/news?id=c1083eb5d78d2494cc5298cb1e9b87db833a0270edea2b3e80d13132b8c82147",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "OPKO Health's 12.4% monthly gain is backed by narrower losses and better margins, though profitability and clinical execution remain key risks.",
                "category": "company",
                "datetime": 1787160900,
                "headline": "OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?"
              },
              {
                "id": 141283677,
                "url": "https://finnhub.io/api/news?id=e5c485442820baef6b2efbdde6716d59d47ff872afaf6e93bbdacc8bd228238b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and the National Association of Community Health Centers (NACHC) today announced a strategic alliance to strengthen leadership development, support practice improvement and advance community health initiatives across the nation's Community Health Center (CHC) network. As part of the collaboration, the organizations are launching the NACHC Leadership Exchange for Chief Medical Officers, designed to support cu",
                "category": "company",
                "datetime": 1787054400,
                "headline": "Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health"
              },
              {
                "id": 141249550,
                "url": "https://finnhub.io/api/news?id=e4a4007233f345246016d931e5f8bdf59aed8a125f2b5b12aef7d10c07478b65",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Collaboration will support leadership development, practice improvement and innovation across the nation's Community Health CentersBURLINGTON, N.C. and BETHESDA, Md., Aug. 18, 2026 /PRNewswire/ -- Labcorp (NYSE:LH),",
                "category": "company",
                "datetime": 1787036885,
                "headline": "Labcorp And NACHC Announce Strategic Alliance To Support Practice Improvement And Advance Community Health Initiatives Across Community Health Center Network"
              },
              {
                "id": 141283671,
                "url": "https://finnhub.io/api/news?id=bc11bca6e6fed5f8b9cc8192451e1dd125d0d9e8ada4eb2d22092d7b3fd87f6d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 10, 2026, from 9 a.m. to noon ET.",
                "category": "company",
                "datetime": 1786971600,
                "headline": "Labcorp to Host Investor Day on September 10, 2026"
              },
              {
                "id": 141231125,
                "url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
                "category": "company",
                "datetime": 1786867596,
                "headline": "IHF: Healthcare Dashboard For August"
              },
              {
                "id": 141206752,
                "url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
                "category": "company",
                "datetime": 1786626060,
                "headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
              },
              {
                "id": 141202443,
                "url": "https://finnhub.io/api/news?id=884f7cde5cf80530f3f3b7a4222766c9d5b1611dd2c9927a81ff8dbcb1403238",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Schechter maintains a $33 million stake after this pre-scheduled sale under a Rule 10b5-1 plan.",
                "category": "company",
                "datetime": 1786570501,
                "headline": "Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million"
              },
              {
                "id": 141195498,
                "url": "https://finnhub.io/api/news?id=52a9e9c710389d8e328c113ec8d19bb6fe8cdf20776be938d5fee35bc4b11809",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced melanoma and nationwide access to Roche's VENTANA PTEN RxDx Assay for prostate cancer. See our latest analysis for Labcorp Holdings. Labcorp Holdings has attracted more attention in recent months, with oncology diagnostics approvals and stronger earnings updates sitting alongside a 30 day share price return of 16.48% and a 1 year total...",
                "category": "company",
                "datetime": 1786554523,
                "headline": "Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?"
              },
              {
                "id": 141195499,
                "url": "https://finnhub.io/api/news?id=113fd9a31a9520a3488b53c1dc4d4d6b3879247f5450043b998c69734cadd53d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "In late July and early August 2026, Labcorp reported higher second-quarter and year-to-date earnings, raised its 2026 revenue growth guidance, completed a large share repurchase program, and expanded its precision oncology offering by making Roche's FDA-approved VENTANA PTEN (SP218) RxDx Assay available nationwide to help guide prostate cancer treatment decisions. Together with the recent FDA approval of its PGDx elio tissue complete CDx for advanced melanoma, these developments reinforce...",
                "category": "company",
                "datetime": 1786513280,
                "headline": "Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative?"
              },
              {
                "id": 141202446,
                "url": "https://finnhub.io/api/news?id=bab940f55a7015d88f60068e2a5c3a85f4cdee542e259b301b823c86d91a00e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "ALC's Q2 earnings and sales beat estimates as equipment and ocular health gains lift results, while the company raises its 2026 EPS outlook.",
                "category": "company",
                "datetime": 1786454220,
                "headline": "Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs"
              },
              {
                "id": 141175551,
                "url": "https://finnhub.io/api/news?id=335ee49202be9ffff32971915dd2c0726283f0b283c39a280888d2ccb6cbefef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and cost risks support a measured view.",
                "category": "company",
                "datetime": 1786373040,
                "headline": "Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?"
              },
              {
                "id": 141175552,
                "url": "https://finnhub.io/api/news?id=eee9f1f73ba5090380f2701c2893296c2b81648f037f5e89f4a44803cadf2233",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Insulet's Q2 results beat estimates on strong Omnipod demand and wider margins, but its 2026 revenue outlook takes a hit.",
                "category": "company",
                "datetime": 1786368120,
                "headline": "PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down"
              },
              {
                "id": 141173754,
                "url": "https://finnhub.io/api/news?id=0f7603567957d6263f1c0c28e1b96d52b004f1603691cc3fddfe295396d66f4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that the U.S. Food and Drug Administration (FDA) has approved Labcorp's PGDx elio® tissue complete CDx as a companion diagnostic to help identify patients with advanced melanoma with certain BRAF variants who may benefit from treatment with FDA-approved targeted therapiesi.",
                "category": "company",
                "datetime": 1786359600,
                "headline": "Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma"
              },
              {
                "id": 141149648,
                "url": "https://finnhub.io/api/news?id=23ea5ce12ca989bc8194b69e7daad6302e9ee390a675376aa73d23dc8c9d4466",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Prestige Consumer's Q1 earnings and revenues outpace estimates as acquisitions boost its fiscal 2027 outlook despite margin pressure.",
                "category": "company",
                "datetime": 1786115820,
                "headline": "PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised"
              },
              {
                "id": 141149640,
                "url": "https://finnhub.io/api/news?id=9330c5d081238104a84cc1a9ddf25b5c9eb1eb96172fe7a4c6eb81db3d1c6b84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.",
                "category": "company",
                "datetime": 1786115520,
                "headline": "RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y"
              },
              {
                "id": 141148177,
                "url": "https://finnhub.io/api/news?id=d125aba8d6bfc00d706132d273626c8dadaedc5c85eb89d47c934fce7ab53293",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median.",
                "category": "company",
                "datetime": 1786113360,
                "headline": "Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation"
              },
              {
                "id": 141122630,
                "url": "https://finnhub.io/api/news?id=f0d3f50c1dc72e766cb1b44a80ca4169797e7933306849ac32ca38bbb7329306",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "CVS beats Q2 earnings and revenue estimates as stronger segment performance lifts results and prompts raised 2026 guidance, sending shares higher.",
                "category": "company",
                "datetime": 1785939600,
                "headline": "CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs"
              },
              {
                "id": 141120805,
                "url": "https://finnhub.io/api/news?id=c7bd52b475fb75372a286906251e0256b3c53c47c1e6c7d37dbd30857513f8f1",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "LH",
                "summary": "As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.",
                "category": "company",
                "datetime": 1785933301,
                "headline": "Wondering what's happening in today's S&P500  pre-market session?"
              },
              {
                "id": 141111550,
                "url": "https://finnhub.io/api/news?id=de33b8a0123d2b292054ba1f29716341249c010c55f9d5ee0e321353a5057f28",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212125572/image_2212125572.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "OPKO Health's Q2 results: IP revenue surged on Nicoya deal and FY2026 guidance rose. Click for this OPK stock update.",
                "category": "company",
                "datetime": 1785851748,
                "headline": "OPKO Health: Mazdutide And MDX-2201 Could Change Everything"
              },
              {
                "id": 141110312,
                "url": "https://finnhub.io/api/news?id=01e5837a924347cd1bedd5dda28d8136eee81b885372098288f763d19df0933a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.",
                "category": "company",
                "datetime": 1785850380,
                "headline": "HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs"
              },
              {
                "id": 141107902,
                "url": "https://finnhub.io/api/news?id=24103420de0414db7e1d1dac26623ef2061b74e82104d0586b92f8eb6de2ca2f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche's VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP®",
                "category": "company",
                "datetime": 1785841200,
                "headline": "Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer"
              },
              {
                "id": 141113826,
                "url": "https://finnhub.io/api/news?id=cb7569dd8f4e97eb03cb01e03d6d0b6d8c8a2fb0337ecd499476112b3e481b16",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone acetate and prednisone.",
                "category": "company",
                "datetime": 1785827584,
                "headline": "Labcorp Announces Availability of Roche's Ventana Pten RxDx Assay, First Immunohistochemistry Companion Diagnostic Test Approved By FDA To Determine Pten Protein Loss In Prostate Adenocarcinoma Patients"
              },
              {
                "id": 141104982,
                "url": "https://finnhub.io/api/news?id=295204cd4af9efb6610e72a4dabb7c24f5d072f220625e367e538daf94479f5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Specialty testing and Central Labs fueled revenue growth and margin expansion.",
                "category": "company",
                "datetime": 1785802612,
                "headline": "Labcorp (LH) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141103820,
                "url": "https://finnhub.io/api/news?id=823ed01ce7e9611533ec93c8f8973be93c55924ea40e9f170dd9140a26d6d8cf",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "2026-08-03. The following slide deck was published by Labcorp Holdings Inc.",
                "category": "company",
                "datetime": 1785783820,
                "headline": "Labcorp Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation"
              },
              {
                "id": 141101207,
                "url": "https://finnhub.io/api/news?id=ab4db3f301def98b9f07aa9343c6e7daf76ba96dee31f403cc70a8426f9e6464",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "DGX raised its 2026 outlook as testing demand surged, but lower-margin deals and rising project costs could temper the payoff.",
                "category": "company",
                "datetime": 1785767820,
                "headline": "Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates"
              },
              {
                "id": 141113827,
                "url": "https://finnhub.io/api/news?id=dc89b5fab8d61b397087a5df33938f16714c5cb726c93e160c9f2d4140779042",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "JP Morgan  analyst Lisa Gill   maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $330 to $360.",
                "category": "company",
                "datetime": 1785757000,
                "headline": "JP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360"
              },
              {
                "id": 141083725,
                "url": "https://finnhub.io/api/news?id=4d79c685225036b140b62d42ebb2df3bbf5c2d184593de5cc537c8916de1b921",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE:LH) has introduced the Marker by Labcorp Genetic Health Panel, a new consumer-focused genetic testing service. The product brings together genetic testing, counseling, and biomarker analysis in one offering for individuals looking to better understand their health risks. The launch uses Labcorp’s existing testing infrastructure alongside new AI-powered platforms to support more tailored insights for consumers. Investors watching Labcorp Holdings now have a fresh data...",
                "category": "company",
                "datetime": 1785539301,
                "headline": "Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing"
              },
              {
                "id": 141083726,
                "url": "https://finnhub.io/api/news?id=41496f8d4329a454733b8c76cbcd2d949f209ba3226e43423edd777467a44f22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.77 billion at the midpoint. Its non-GAAP profit of $4.99 per share was 4.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785538797,
                "headline": "LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase"
              },
              {
                "id": 141079209,
                "url": "https://finnhub.io/api/news?id=a6471e0133a67e636ec4594009b47f90824127b7b349df3ce876842b2945e378",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Quest Diagnostics' earnings beat, raised 2026 outlook and broad testing demand support momentum, but valuation, debt and margin pressure temper the buy case.",
                "category": "company",
                "datetime": 1785506760,
                "headline": "Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?"
              },
              {
                "id": 141082936,
                "url": "https://finnhub.io/api/news?id=49059c5e68fe177d6e5e43ae78e8b525eba4696de1d6680cc38fa47b7774a7f2",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Morgan Stanley  analyst Ricky Goldwasser   maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $308 to $338.",
                "category": "company",
                "datetime": 1785504806,
                "headline": "Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338"
              },
              {
                "id": 141077343,
                "url": "https://finnhub.io/api/news?id=f2e25a42d60925be47c9292035c4cc5b7b44eec525e414a61a8df9c04ad0aea0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE:LH) reported second-quarter 2026 revenue growth, margin expansion and higher adjusted earnings, prompting the laboratory services company to raise the midpoint of its full-year revenue and adjusted EPS guidance. Revenue rose 5.8% year over year to $3.7 billion, while adjusted operatin",
                "category": "company",
                "datetime": 1785499436,
                "headline": "Labcorp Q2 Earnings Call Highlights"
              },
              {
                "id": 141082937,
                "url": "https://finnhub.io/api/news?id=7477147161e32aea63e2a409207eb918f3229c11ff2689d1ecea8776d3466384",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Truist Securities  analyst David Macdonald   maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $320 to $350.",
                "category": "company",
                "datetime": 1785489521,
                "headline": "Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350"
              },
              {
                "id": 141082938,
                "url": "https://finnhub.io/api/news?id=db80625b984fc0398592fca2b035373ca8965b0536eb37c9c23321fe47d26b3e",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Barclays  analyst Jack Meehan   maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises the price target from $290 to $320.",
                "category": "company",
                "datetime": 1785484908,
                "headline": "Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $320"
              },
              {
                "id": 141077344,
                "url": "https://finnhub.io/api/news?id=fbdfdc7a0067dac452a2fbf3a4c3b51ec16dba606aa78120e2a1b1265bffe0a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Moby summary of Labcorp Holdings Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1785464431,
                "headline": "Labcorp Holdings Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141071591,
                "url": "https://finnhub.io/api/news?id=2836594e64296607bb7f6e294cf33070ec4c9783ecab2f8b748f782468ecb239",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "The telehealth company is making a bold pivot that's driving growth, but the stock's recent slide has investors wondering if the price of admission is still too high.",
                "category": "company",
                "datetime": 1785447512,
                "headline": "Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy?"
              },
              {
                "id": 141071710,
                "url": "https://finnhub.io/api/news?id=d549868b4a230c3a0c0c3c7ad7bf79f11d867424ed4dbfab41fcb66c19e2fde6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc (LH) reports a 6% revenue increase to $3.7 billion and raises full-year 2026 guidance, driven by double-digit growth in specialty testing and robust Biopharma segment performance.",
                "category": "company",
                "datetime": 1785445728,
                "headline": "Labcorp Holdings Inc (LH) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ..."
              },
              {
                "id": 141068616,
                "url": "https://finnhub.io/api/news?id=40b44f41e63b7857e9e36a8644fb6508a1c4e9f44f4936c01762e026d58a57b8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "DGX's broad testing demand, payer access, advanced diagnostics and partnerships support 2026 growth as AI and automation target costs.",
                "category": "company",
                "datetime": 1785429240,
                "headline": "Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026"
              },
              {
                "id": 141068617,
                "url": "https://finnhub.io/api/news?id=05552d6ffcc25a073722abed7f9de34a3d2ebb547fb64e72bc837087eb718b16",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp's Q2 earnings and revenues surpass estimates, margins expand, and its 2026 outlook is raised, but shares fall 6% in pre-market trading.",
                "category": "company",
                "datetime": 1785425340,
                "headline": "LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Rise"
              },
              {
                "id": 141069063,
                "url": "https://finnhub.io/api/news?id=143177d8f1fb7ff7ef9861ff610a92acb5586305f8dca5604f2f600c1f832396",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call July 30, 2026 9:00 AM EDTCompany ParticipantsDewey SteadmanAdam Schechter - President, CEO &...",
                "category": "company",
                "datetime": 1785422617,
                "headline": "Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141067158,
                "url": "https://finnhub.io/api/news?id=33bacf1bb84aba0f02b78af8a840bf384f9678cba4cac23714f0f29daeca1a74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785418208,
                "headline": "Labcorp (LH) Reports Q2 Earnings: What Key Metrics Have to Say"
              },
              {
                "id": 141065045,
                "url": "https://finnhub.io/api/news?id=bf1e50847e33ed20493dcf949388c5f80c0af11365937bdb1f67e964fbeb274e",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "LH",
                "summary": "Pre-market stock analysis of S&P500 stocks on 2026-07-30: top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1785414901,
                "headline": "Top S&P500 movers in Thursday's pre-market session"
              },
              {
                "id": 141065738,
                "url": "https://finnhub.io/api/news?id=f9ea910944592125e763e4b1d78de01dfefa32a4e9fa71cdcb9bc19399caabfb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.77 billion at the midpoint. Its non-GAAP profit of $4.99 per share was 4.6% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785414086,
                "headline": "Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations"
              },
              {
                "id": 141065739,
                "url": "https://finnhub.io/api/news?id=6618846bf26ab3a14d10f4dc4d9a3c586835743bd45dffefe2ba138568c50198",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) delivered earnings and revenue surprises of +4.18% and +0.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785413104,
                "headline": "Labcorp Holdings (LH) Surpasses Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 141064393,
                "url": "https://finnhub.io/api/news?id=63c69866d2616537433ee7aa95aa04755a43a6385e77cd744391509841acb232",
                "image": "https://www.chartmill.com/images/uploads/earnings_article_1_defce97180.webp",
                "source": "ChartMill",
                "related": "LH",
                "summary": "Labcorp Q2 revenue of $3.73B missed estimates, but EPS beat at $4.99. Stock fell 4.6% pre-market despite raised 2026 guidance.",
                "category": "company",
                "datetime": 1785411770,
                "headline": "Labcorp (NYSE:LH) Shares Slide on Q2 Revenue Miss Despite Earnings Beat"
              },
              {
                "id": 141064737,
                "url": "https://finnhub.io/api/news?id=ab91a078e69fc369449491fe9292de964ef0a357f6d1799be13e4345814ea44c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2026 and updated its full-year financial guidance.",
                "category": "company",
                "datetime": 1785408600,
                "headline": "Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance"
              },
              {
                "id": 141071923,
                "url": "https://finnhub.io/api/news?id=20108261b2f7522dc6a634692c8c1e078b5bb935afd32d18463e306a92bd17fb",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $17.70-$18.35 to $18.10-$18.55 vs $18.01 analyst estimate. Raises FY2026 sales outlook from $14.650 billion-$14.800 billion to $14.710 billion-$14.827",
                "category": "company",
                "datetime": 1785394308,
                "headline": "Labcorp Holdings Raises FY2026 Adj EPS Guidance from $17.70-$18.35 to $18.10-$18.55 vs $18.01 Est; Raises FY2026 Sales Guidance from $14.650B-$14.800B to $14.710B-$14.827B vs $14.707B Est"
              },
              {
                "id": 141071924,
                "url": "https://finnhub.io/api/news?id=73fad9dadcb00cb27f870564107d2776c825dfa37d77938ce8ce0a27ecbbb2fd",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.99 per share which beat the analyst consensus estimate of $4.78 by 4.39 percent. This is a 14.71 percent increase over earnings of $4.35 per share from the",
                "category": "company",
                "datetime": 1785394259,
                "headline": "Laboratory Corp Q2 Adj. EPS $4.99 Beats $4.78 Estimate, Sales $3.731B Beat $3.711B Estimate"
              },
              {
                "id": 141055986,
                "url": "https://finnhub.io/api/news?id=db6e2946fda15a4e09e7d914147e1ea27b826809004a68a8b85f05d1620de765",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Thursday before market hours. Here’s what to look for.",
                "category": "company",
                "datetime": 1785346862,
                "headline": "What To Expect From Labcorp’s (LH) Q2 Earnings"
              },
              {
                "id": 141054553,
                "url": "https://finnhub.io/api/news?id=c0370060b1ba7dc9dcab546154a903228728da67f40ef9adfaf1770f48669f0e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Labcorp (LH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785330925,
                "headline": "Labcorp (LH) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates"
              },
              {
                "id": 141054225,
                "url": "https://finnhub.io/api/news?id=41aa526220e6ca239ab5014e1a1a76b5e395a007395bd137b135590ae8524e63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "ZBH heads into Q2 earnings with expectations of modest revenue growth as investors watch demand trends across knees, hips and robotics.",
                "category": "company",
                "datetime": 1785329880,
                "headline": "Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 141043753,
                "url": "https://finnhub.io/api/news?id=26ad68828352e6c29c891a3dfad45b0b89d2bac7a4cc44630baee9cb00c94ea1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "HSIC heads into Q2 earnings with expectations for revenue and EPS growth as dental, specialty products and AI-enabled technology remain in focus.",
                "category": "company",
                "datetime": 1785245100,
                "headline": "Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 141037184,
                "url": "https://finnhub.io/api/news?id=22c4f92f3c88f3a96febcbbeb9e4c85d408b1e74e67000b972ad008f6e93b1f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Bank of America's trading, investment banking and digital expansion drive growth, but rising costs and market volatility pose key challenges.",
                "category": "company",
                "datetime": 1785183300,
                "headline": "Top Stock Reports for Bank of America, Netflix & TotalEnergies"
              },
              {
                "id": 141032302,
                "url": "https://finnhub.io/api/news?id=d0f43c1bd24348255c879346e693ffebd977e061af8d4fb785a2c68cddcb3e01",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker by Labcorp™ Genetic Health Panel, a new offering designed to help consumers better understand inherited risks associated with more than 100 medically actionable health conditions. Available through Labcorp OnDemand, the panel analyzes 163 genes associated with hereditary cancer, cardiovascular conditions and metabolic conditions and includes access to licensed genetic cou",
                "category": "company",
                "datetime": 1785153600,
                "headline": "Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.5,
            "source_article_count": 57,
            "discarded_article_count": 43
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.2,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.7,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(23%→7.2%)；跌縮量(近10日3日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 733636.6666666666,
              "down_days": 3,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 555180,
              "avg_vol_20": 687840,
              "avg_vol_30": 733636.6666666666,
              "range_pct_10": 0.07234666170180831,
              "range_pct_20": 0.13450607481953566,
              "range_pct_30": 0.22995149934705947,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7567506167903276,
              "dist_to_20d_high": 0.006122027133211019,
              "down_shrink_days": 3,
              "breakout_level_20d": 339.76001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.3146170471044309
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.0171168567021103,
              "turnoverUsdM": 235.49701198602997,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.LH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 324.0572,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4,
            "take_profit_price": 354.564,
            "target_multiplier": 1.9,
            "technical_strength": 1.85,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2393927459846728,
          "stopLossPercent": 4.0342337134042205,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 6.8114,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.02
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 142.7
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "資金流入",
      "score": 8,
      "value": 0.2367
    },
    "kdj": {
      "d": 86.23,
      "j": 95.94,
      "k": 89.47,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 80.32
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 7031603,
      "recentSlope": 122040.3,
      "previousSlope": 311800
    },
    "rsi": 79.61,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 330.2489,
      "position": "SAR喺價下",
      "distancePct": 2.2,
      "previousTrend": "上升"
    },
    "ma50": 295.1718,
    "macd": {
      "macd": 11.812238660809555,
      "trend": "強烈看漲",
      "signal": 11.261388201201155,
      "histogram": 0.5508504596083998
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 319.1859,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 41
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.05,
      "score": 6,
      "avgVolume": 665900,
      "currentVolume": 697397
    },
    "derived": {
      "ma20": 321.568,
      "ma50": 295.1718,
      "prevClose": 339.34,
      "avgVolume10": 573660,
      "avgVolume20": 665900,
      "changePercent": -0.49,
      "avgVolumeForScore": 665900
    },
    "ma_cross": {
      "ma20": 321.568,
      "ma50": 295.1718,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 320.3955,
      "prevMa50": 293.7414,
      "spreadPct": 8.94,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 302.6407,
      "upper": 340.4953,
      "position": "上半部"
    },
    "rsi_short": 85.89,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.05
    }
  }
}

{
  "close": 337.68,
  "volume": 697397,
  "changePercent": -0.49
}